Evidence map›Paper›PMID 39363909›Full record

ArticleDemographic research

Probabilistic forecasting of maximum human lifespan by 2100 using Bayesian population projections.

Michael Pearce, Adrian Raftery

Abstract read
In one paragraph

Article in Demographic research. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Human mortality at extreme age.Royal Society open science · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Michael PearceDepartments of Statistics, University of Washington, USA.
Adrian RafteryDepartments of Statistics and Sociology, University of Washington, USA.

Funding

Statistical Methods for Population ProjectionsR01HD070936 · NICHD · UNIVERSITY OF WASHINGTON · PI RAFTERY, ADRIAN E · 2012 to 2021
$3.3M
NICHD NIH HHS R01 HD070936
6 · The paper itself

Abstract

backgroundWe consider the problem of quantifying the human lifespan using a statistical approach that probabilistically forecasts the maximum reported age at death (MRAD) through 2100.

objectiveWe seek to quantify the probability that any person attains various extreme ages, such as those above 120, by the year 2100.

methodsWe use the exponential survival model for supercentenarians (people over age 110) of Rootzén and Zholud (2017) but extend the forecasting window, quantify population uncertainty using Bayesian population projections, and incorporate the most recent data from the International Database on Longevity (IDL) to obtain unconditional estimates of the distribution of MRAD this century in a fully Bayesian analysis.

resultsWe find that the exponential survival model for supercentenarians is consistent with the most recent IDL data and that projections of the population aged 110-114 through 2080 are sensible. We integrate over the posterior distributions of the exponential model parameter and uncertainty in the supercentenarian population projections to estimate an unconditional distribution of MRAD by 2100.

conclusionsBased on the Bayesian analysis, there is a greater than 99% probability that the current MRAD of 122 will be broken by 2100. We estimate the probabilities that a person lives to at least age 126,128, or 130 this century, as 89%, 44%, and 13%, respectively. CONTRIBUTION: We have updated the supercentenarian survival model of Rootzén and Zholud using the most recent IDL data, incorporated Bayesian population projections, and extended the forecasting window to create the first fully Bayesian and unconditional probabilistic projection of MRAD by 2100.

Identifiers

PMID39363909
PMCPMC11448547

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.